Publicaciones en las que colabora con María Inmaculada Dominguez Mozo (16)

2021

  1. Evolution of antibody titres against Epstein–Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Acetate correlates with disability and immune response in multiple sclerosis

    PeerJ, Vol. 8

2017

  1. Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort

    European Journal of Clinical Investigation, Vol. 47, Núm. 2, pp. 158-166

2016

  1. Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients

    European Journal of Neurology, Vol. 23, Núm. 1, pp. 182-189

2014

  1. Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis

    PLoS ONE, Vol. 9, Núm. 8

  2. HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV

    Retrovirology, Vol. 11, Núm. 1

  3. Toll-like receptor-9 in Spanish multiple sclerosis patients: An association with the gender

    European Journal of Neurology, Vol. 21, Núm. 3, pp. 537-540

2013

  1. Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of spanish multiple sclerosis patients treated with natalizumab

    Journal of Neuroimmune Pharmacology, Vol. 8, Núm. 5, pp. 1277-1286

  2. The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up

    BMC Neurology, Vol. 12

2011

  1. CD46 in a Spanish cohort of multiple sclerosis patients: Genetics, mRNA expression and response to interferon-beta treatment

    Multiple Sclerosis Journal, Vol. 17, Núm. 5, pp. 513-520

  2. Herpesvirus active replication in multiple sclerosis: A genetic control?

    Journal of the Neurological Sciences, Vol. 311, Núm. 1-2, pp. 98-102

  3. Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients

    European Journal of Neurology, Vol. 18, Núm. 8, pp. 1027-1035

2010

  1. MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients

    European Journal of Neurology, Vol. 17, Núm. 1, pp. 129-135

  2. Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: A two-year follow-up study

    European Journal of Neurology, Vol. 17, Núm. 3, pp. 470-478

2009

  1. CD46 expression and HHV-6 infection in patients with multiple sclerosis

    Acta Neurologica Scandinavica, Vol. 120, Núm. 4, pp. 246-250